Free Newsletter
Hoffman's Accutane on trial
Does Accutane cause inflammatory bowel disease? That was the question on everyone's mind in a federal appeals court yesterday when attorneys asked a three-judge panel to admit testimony from an expert witness who says that it does.
Spokespersons at Hoffman-La Roche, the drug's manufacturer, says that there is no connection between the chronic bowel condition and the popular acne medication, but in at least three multi-million dollar lawsuits, the courts seem to disagree.
And plaintiff lawyers say there are hundreds more similar cases on the horizon, many of which will hinge on the provision of the types of expert testimony under consideration in the court yesterday.
The drug company, in fact, has noted an association with inflammatory bowel disease on the Accutane label, yet maintains that the drug--which has been on the market for about a quarter century--does not cause the condition.
--read the story at Forbes
--find out more at WTVM
Related Article:
FDA requires all Accutane users to register first
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: